Importance Anthracyclines treat a broad range of cancers. Basic and retrospective clinical
data have suggested that use of atorvastatin may be associated with a reduction in cardiac …

Background The glucose-lowering independent effect of sodium glucose cotransporter-2
inhibitors (SGLT2i) on arterial wall function has not yet been clarified. This study aims to assess …

Background There are limited data on the occurrence, associations and outcomes of pericardial
effusions and pericarditis on or after treatment with immune checkpoint inhibitors (ICIs). …

Background and aims The new coronavirus disease (COVID-19) is a systemic disease.
Mounting evidence depict signs and symptoms involving multiple organs, most of which …

Background Preclinical studies indicate that the concurrent use of inhibitors of the renin–angiotensin–aldosterone
system (RAAS) may improve outcomes in broad groups of patients …

Background Left atrial (LA) and left ventricular (LV) structural and functional parameters
have independent prognostic values as predictors of atrial fibrillation (AF). Purpose To …

Background Coronary vasospasm is a known side effect of 5-FU (fluorouracil) therapy. Beyond
switching to non-5FU-based chemotherapy, there are no established treatments for 5-FU …

Background Global circumferential strain (GCS) and global radial strain (GRS) are reduced
with cytotoxic chemotherapy. There are limited data on the effect of immune checkpoint …

Background Sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve endothelial dysfunction
and reduce cardiovascular events in individuals with type 2 diabetes (T2D). Proprotein …

We compared the effect of dapagliflozin versus glibenclamide on the ratio of lean-to total
mass in patients with type 2 diabetes mellitus, carotid subclinical atherosclerosis, HbA1c 7.0–…